DCGI nod to commercial launch of India's first low-cost COVID-19 test 'FELUDA' : Bulletin: Business Today
Business Today
Loading...
 

DCGI nod to commercial launch of India's first low-cost COVID-19 test 'FELUDA'

Loading the player...

Rashi Bisaria | September 21, 2020

Farm bills passed in Rajya Sabha amid protests by opposition MPs

The Rajya Sabha has passed the Farmers' and Produce Trade and Commerce (Promotion and Facilitation) Bill, 2020 and Farmers (Empowerment and Protection) Agreement on Price Assurance and Farm Services Bill, 2020, through voice vote amid protest by opposition MPs and farmers' protests across Punjab and Haryana. The bills were passed in the Lok Sabha last week.

Tata Consultancy Services sets up 11 COVID-19 isolation centres for staff, dependents

India's largest software services firm Tata Consultancy Services (TCS) has set up 11 first-line COVID-19 isolation centres within its premises in various cities in India, including Mumbai, Indore and Nagpur. These centres will provide medical support to associates and their dependents (spouse, children and parents/parents-in-law) who are asymptomatic or mildly COVID-19 positive with no other co-morbidities.

Govt plans to let firms with 300 workers fire staff without its nod

Companies with not less than 300 workers will soon be allowed to hire and fire workers without seeking prior nod from the government. These changes have been proposed in The Industrial Relations Code Bill, 2020, introduced in Lok Sabha Saturday. As of now, only those industrial establishments with less than 100 employees are permitted to hire and fire their staff without permission of the government.

DCGI nod to commercial launch of India's first low-cost COVID-19 test 'FELUDA'

The Drugs Controller General of India (DCGI) has approved the commercial launch of India's first low-cost COVID test 'FELUDA' for commercial use. The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and the Council of Scientific and Industrial Research (CSIR)- Institute of Genomics and Integrative Biology (IGIB) have jointly developed the COVID-19 test.

COVID-19 vaccine: Serum Institute to begin final phase of trial from Monday

The final clinical trial of coronavirus vaccine by Oxford University and being manufactured by the Serum Institute of India (SII) will begin at the Sassoon General Hospital in Pune from Monday. Some volunteers have already come forward for the trial. Around 150 to 200 volunteers will be administered the vaccine candidate dose.

Rajya Sabha passes bill to punish those attacking healthcare workers

The Rajya Sabha on Saturday passed a legislation that provides for up to five years in jail for those attacking doctors and healthcare workers fighting the COVID-19 outbreak or during any situation akin to the current pandemic. The Epidemic Diseases (Amendment) Bill, 2020 was introduced by Health Minister Dr Harsh Vardhan in the Upper House on Saturday to replace an ordinance issued by the government in April.

Fuel demand to tumble 11.5% in 2020: Fitch Solutions

Fitch Solutions has revised downward its forecast for fuel demand contraction in India to 11.5 per cent in 2020 in line with further deterioration in the country's economic outlook. Its economists forecast India's real GDP to contract by 8.6 per cent in the fiscal year 2020-21 (April 2020 to March 2021), down from -4.5 per cent previously. They have made a further downward revision to their India refined fuels demand forecast for 2020, from -9.4 per cent to -11.5 per cent, in line with further deterioration in the country's economic outlook.

More from this section